Wednesday 9th August 2017 |
Text too small? |
Blis Technologies chief financial officer Tim Mepham has stepped down as the probiotics maker edges closer to turning a profit.
The Dunedin-based company said Mepham will leave "in the coming months to pursue other business interests" and it is searching for a full-time replacement. Mepham has been performing the role four days a week, it said.
Last month, Blis said it expects to post a maiden profit in the current financial year. The company, which was set up to commercialise probiotic bacteria for use in consumer products for oral health, colds and flu, reported a net loss of $24,000 in the 12 months ended March 31, narrowing from a loss of $816,000 a year earlier.
Blis had forecast a profit for the 2017 financial year but warned the market in February that pre-tax profit wasn't going to meet the $700,000 forecast due to significant reductions in purchases by three major customers.
The stock last traded at 3.5 cents and has shed 13 percent this year.
(BusinessDesk)
No comments yet
July 8th Morning Report
Half-way predictions scorecard
SKT - Sky appoints new Chief Financial Officer
July 7th Morning Report
CDC Independent Valuation - 30 June 2025
TruScreen Group Limited SPP Update
THL provides updated guidance
CEN - Greymouth gas deal
July 4th Morning Report
July 3rd Morning Report